O, A., & S, G. (2026). Measuring the improvement in overall survival among patients with advanced gastroenteropancreatic neuroendocrine tumors over the past two decades. Scandinavian journal of gastroenterology, 61(6), 617. https://doi.org/10.1080/00365521.2026.2648052
Chicago Style (17th ed.) CitationO, Abdel-Rahman, and Ghosh S. "Measuring the Improvement in Overall Survival Among Patients with Advanced Gastroenteropancreatic Neuroendocrine Tumors over the Past Two Decades." Scandinavian Journal of Gastroenterology 61, no. 6 (2026): 617. https://doi.org/10.1080/00365521.2026.2648052.
MLA (9th ed.) CitationO, Abdel-Rahman, and Ghosh S. "Measuring the Improvement in Overall Survival Among Patients with Advanced Gastroenteropancreatic Neuroendocrine Tumors over the Past Two Decades." Scandinavian Journal of Gastroenterology, vol. 61, no. 6, 2026, p. 617, https://doi.org/10.1080/00365521.2026.2648052.